NCT02351427View on ClinicalTrials.gov

Bortezomib With Steroid Pulse Therapy for Acute Cellular Rejection in Kidney Transplantation

PHASE3UnknownINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

February 28, 2015

Primary Completion Date

December 31, 2015

Study Completion Date

December 31, 2015

Conditions
Kidney Transplantation
Interventions
DRUG

Bortezomib

In one group, investigators administer bortezomib and steroid to manage acute cellular rejection in kidney transplantation, and compare the results with another group in which only steroid was administered.

DRUG

Steroid

Investigators administer steroid in both groups for conventional treatment of acute cellular rejection.

Trial Locations (1)

138-736

RECRUITING

Asan Medical Center, Seoul

Sponsors
All Listed Sponsors
lead

Asan Medical Center

OTHER

NCT02351427 - Bortezomib With Steroid Pulse Therapy for Acute Cellular Rejection in Kidney Transplantation | Biotech Hunter | Biotech Hunter